RE:RE:RE:Now - look at Wallace's work related to western diets ...Correct - this is recent work.
Obviously 340 would required a redesign but that's in line with IBD and the new antiviral (ATB-344). It would likely morph out of the learning that comes from those designs ... and ... it would likely come with 20 year IP.
But ... too much on the go ... I'm not looking for any quick move into 340 at this time.
------------------------
Too much underway with 346 and Phase 2.
Too much to do with IBD and antiviral.
Likely working on neuro-inflammation science now (latest work in Alzheimer's has me wondering if IBD and the antiviral will be tested in combination - and separately - when it comes to brain diseases)
Then - we could be into 340 (as per the funnel in the presentation). I read it in clockwise fashion and assume that to be the order. Best guess for now - don't have much else to go on.
Good Luck !